Indrayani Biotec
BSE: INDRANIB · Other Agricultural Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Indrayani Biotec's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Indrayani Biotec Limited is a diversified Indian conglomerate operating across healthcare, food and hospitality, engineering, and agriculture sectors. The company leverages a subsidiary-based model to provide diagnostic services, industrial catering, and specialized manufacturing solutions.
Business Model
The company generates revenue through a conglomerate structure, offering services ranging from pharmaceutical distribution and medical equipment supply to industrial catering and solar energy solutions. It focuses on integrating technology-driven solutions across its diverse portfolio of traditional and emerging industries.
Management Commentary
Management continues to pursue a conglomerate-style growth strategy, focusing on expanding the company's footprint across its various business verticals.
Growth Outlook
Growth is driven by the expansion of its subsidiaries and joint ventures, with a strategic emphasis on scaling its healthcare and engineering divisions.
Key Risks
- Operational Complexity. Managing a highly diversified portfolio across unrelated sectors may lead to inefficiencies and diluted management focus.
- Regulatory Risk. The company is subject to varying regulatory frameworks across the healthcare, food, and energy sectors, which could impact operational costs.
- Market Competition. The company faces intense competition in its various business segments from both established players and agile startups.
- Economic Sensitivity. As a conglomerate, the company is susceptible to broader macroeconomic fluctuations affecting consumer spending and industrial demand in India.
Start your research today
Unlock AI insights, financials, peers and live data on Indrayani Biotec and 5,000+ companies — free.
Peers · Other Agricultural Products
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Indrayani BiotecINDRANIB | ₹73 Cr | — | — | — | 7.3% | — | — | -21.4% |
Bombay Super Hybrid Seeds LimitedBSHSL | ₹898 Cr | 30.42 | 26.04 | 8.0% | 10.1% | 24.3% | 30.9% | -33.9% |
Mangalam Global Enterprise LimitedMGEL | ₹510 Cr | 10.65 | 8.83 | 41.4% | 2.3% | 19.0% | 34.2% | -10.3% |
Sukhjit Starch & Chemicals LimitedSUKHJITS | ₹508 Cr | 13.80 | 7.61 | -0.9% | 7.5% | 6.2% | 10.2% | -7.6% |
Modi NaturalsMODINATUR | ₹469 Cr | 8.20 | 8.00 | 7.3% | 10.9% | 35.6% | 29.7% | -23.4% |
Sarveshwar FoodsSARVESHWAR | ₹451 Cr | 6.25 | 9.78 | 16.4% | 5.1% | 8.4% | 17.4% | -43.9% |
As of Mar 2026
Financials
Indrayani Biotec
BSE: INDRANIB · Other Agricultural Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Indrayani Biotec's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Indrayani Biotec Limited is a diversified Indian conglomerate operating across healthcare, food and hospitality, engineering, and agriculture sectors. The company leverages a subsidiary-based model to provide diagnostic services, industrial catering, and specialized manufacturing solutions.
Business Model
The company generates revenue through a conglomerate structure, offering services ranging from pharmaceutical distribution and medical equipment supply to industrial catering and solar energy solutions. It focuses on integrating technology-driven solutions across its diverse portfolio of traditional and emerging industries.
Management Commentary
Management continues to pursue a conglomerate-style growth strategy, focusing on expanding the company's footprint across its various business verticals.
Growth Outlook
Growth is driven by the expansion of its subsidiaries and joint ventures, with a strategic emphasis on scaling its healthcare and engineering divisions.
Key Risks
- Operational Complexity. Managing a highly diversified portfolio across unrelated sectors may lead to inefficiencies and diluted management focus.
- Regulatory Risk. The company is subject to varying regulatory frameworks across the healthcare, food, and energy sectors, which could impact operational costs.
- Market Competition. The company faces intense competition in its various business segments from both established players and agile startups.
- Economic Sensitivity. As a conglomerate, the company is susceptible to broader macroeconomic fluctuations affecting consumer spending and industrial demand in India.
Start your research today
Unlock AI insights, financials, peers and live data on Indrayani Biotec and 5,000+ companies — free.
Peers · Other Agricultural Products
As of Mar 2026